This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Reuben Tizes, MD, MPH; Mahfouz H. Zaki Dr, MD
Brooklyn, NY

JAMA. 1970;214(10):1887.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor:—

In a recent editorial (212:2113,1970) on "Primary Drug Resistance in Tuberculosis" an opinion was expressed that

In the United States, Canada, and several countries in Europe, where large surveys have been instituted and compared for several years with the use of similar bacteriological and clinical criteria, the problem of primary drug resistance is relatively small.

Furthermore, it is stated in the above editorial that "there appears to be no evidence that primary resistance to streptomycin, isoniazid, and aminosalicylic acid is increasing." We are, however, taking strong exceptions to statements expressed in the editorial because of the following:

Many of the surveys referred to by the author have been conducted in the late 50s and very early 60s, a short period following the introduction of isoniazid.

In addition, a great many studies have been limited to select population groups.

One can not generalize and make strong statements . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?